Category: Baxter International
Baxter International's medical products division gets a major boost in the company's 1st quarter, pushing adjusted per-share earnings 9¢ above expectations.
Illinois healthcare titan Baxter (NYSE:BAX) isn't getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.
Here's a look at some of the top personnel stories for medical device companies this week.
Malta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.
Here's a look at some of the top Wall Street stories for medical device companies this week.
, American College of Cardiology
, Arterial Remodeling Technologies
, Baxter International
, Edwards Lifesciences
, K-C Health Care
, Kimberly-Clark Worldwide Inc.
, Smith & Nephew
, Terumo Corp.
, Urologix Inc.
, Abbott Laboratories
Healthcare giant Baxter is slated to add 30 new jobs at a Malta facility, according to local reports.
Updated April 2, 2014, at 3:10 p.m. EST with comments from Baxter.
Malta regulators announced this week that healthcare titan Baxter (NYSE:BAX) plans to add 30 additional jobs in the country.
Baxter International says it plans to go the way of rivals Abbott and Covidien in splitting its pharmaceuticals and medical products businesses into separate companies.
Federal regulators close an investigation into Baxter's Chinese operations without taking any action against the healthcare giant.
MASSDEVICE ON CALL — Baxter (NYSE:BAX) closed the books on a federal bribery investigation after regulators dropped the probe without finding wrongdoing, the company announced.
The FDA warns Baxter International about problems with its HomeChoice dialysis device and with drug infusion pumps made at a pair of plants.
The FDA sent warning letters to Baxter (NYSE:BAX) this year, flagging infractions at an Illinois plant where Baxter makes its HomeChoice dialysis device and at a California plant that makes drug infusion pumps.